Incidence of Esophageal Lichen Planus in Patients With Known Oral Lichen Planus

Sponsor
Ruhr University of Bochum (Other)
Overall Status
Unknown status
CT.gov ID
NCT02532166
Collaborator
(none)
50
2
1
59
25
0.4

Study Details

Study Description

Brief Summary

The lichen planus is a mucocutaneous disease of unknown etiology with an incidence of 1-2%, that affects in 30-70% of cases either the mucosa of the mouth, or partly in combination with infection of the skin, the oral with his known premalignant potential in up to 2-3% predisposed to the development of an oral squamous cell carcinoma.In rare cases, there is also an manifestation of the lining of the esophagus, which can then be associated with symptomatic strictures of the esophagus.

The value of moreover increasingly established endoscopic imaging procedures are investigated as well as data of the natural long-term outcome in esophageal lichen planus infestation especially in view of malignant transformation.

Condition or Disease Intervention/Treatment Phase
  • Other: Esophageal lichen planus
N/A

Detailed Description

The lichen planus is a mucocutaneous disease of unknown etiology that manifests itself with an incidence of 1-2% in 30-70% of cases either at the mucosa of the mouth, or partly in combination with infection of the skin, the oral with his known premalignant potential in up to 2-3% predisposed to the development of an oral squamous cell carcinoma. In rare cases, there is also an manifestation of the lining of the esophagus, which can then be associated with symptomatic strictures of the esophagus. In addition, four cases have been reported with esophageal squamous cell carcinoma in patients with esophageal lichen planus.

The value of moreover increasingly established use of narrow-band imaging (a process for improving the detection of early cancers in the gastrointestinal tract by creating a maximum contrast between outright and altered mucosa, which could have already shown an improved detection rate of early lesions of the esophagus as well as squamous cell carcinoma), or the chromoendoscopy has means for example Lugol solution in correlation to the histopathologic findings in lichen planus), has not been investigated to date.

Also, data of the natural long-term outcome in esophageal lichen planus infestation especially in view of malignant transformation are currently not available.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Incidence of Esophageal Lichen Planus in Patients With Known Oral Lichen Planus. Diagnostic Value of White Light Endoscopy, Narrow Band Imaging and Chromoendoscopy for Detection of Esophageal Manifestation in Patients With Oral Lichen.
Study Start Date :
Jan 1, 2012
Anticipated Primary Completion Date :
Dec 1, 2015
Anticipated Study Completion Date :
Dec 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Other: Esophageal lichen planus

White light endoscopy compared to narrow band imaging and chromoendoscopy with Lugol for detection of esophageal lichen.

Other: Esophageal lichen planus
White light endoscopy compared to narrow band imaging and Lugol for detection of esophageal lichen.

Outcome Measures

Primary Outcome Measures

  1. Value of additional endoscopic enhancing imaging methods for detection of esophageal lichen planus. [3-5 years]

Secondary Outcome Measures

  1. Natural long-term incidence of esophageal lichen planus in patients with known oral lichen. [3-5]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age ≥ 18 years

  • Known lichen planus of the oral mucosa

Exclusion Criteria:
  • Severe cardiopulmonary disease - ASA (American Society of Anaesthesiology) class > III

  • Antisecretory and nonsteroidal anti-inflammatory medication within the last month

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Medicine Bochum Germany 44892
2 Klinikum Agness Karll Laatzen Laatzen Germany 30880

Sponsors and Collaborators

  • Ruhr University of Bochum

Investigators

  • Principal Investigator: Andrea Riphaus, PD Dr, Department of Medicine, KRH Laatzen

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Andrea Riphaus, PD Dr. Andrea Riphaus, Ruhr University of Bochum
ClinicalTrials.gov Identifier:
NCT02532166
Other Study ID Numbers:
  • 2011-4072
First Posted:
Aug 25, 2015
Last Update Posted:
Aug 25, 2015
Last Verified:
Aug 1, 2015
Keywords provided by Andrea Riphaus, PD Dr. Andrea Riphaus, Ruhr University of Bochum
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 25, 2015